Literature DB >> 8089934

Diuretic and natriuretic effect of ebelactone B in anesthetized rats by inhibition of a urinary carboxypeptidase Y-like kininase.

M Majima1, Y Kuribayashi, Y Ikeda, K Adachi, H Kato, M Katori, T Aoyagi.   

Abstract

Ebelactone B (EB) (10(-7)-10(-5) M) inhibited dose-dependently carboxypeptidase (CP) Y-like exopeptidase, one of the major kininases separated from rat urine, whereas it inhibited neither CPA, CPB or neutral endopeptidase (NEP). Degradation of bradykinin (BK) to BK-(1-8) in rat urine was completely inhibited by EB (10(-5) M) with the increased generation of BK-(1-7). Intraduodenal administration of EB (3 mg/kg) to anesthetized rats caused marked diuresis (by 110%) and natriuresis (130%), in parallel with the increase in urinary kinin levels (110%). Intravenous infusion of a BK antagonist, Hoe140 (3 mg/kg/hr), strongly blocked both EB-induced diuresis and natriuresis. EB may be a novel type of diuretic and natriuretic agent that acts by increasing urinary kinin levels.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8089934     DOI: 10.1254/jjp.65.79

Source DB:  PubMed          Journal:  Jpn J Pharmacol        ISSN: 0021-5198


  6 in total

1.  Reduction of sodium deoxycholic acid-induced scratching behaviour by bradykinin B2 receptor antagonists.

Authors:  I Hayashi; M Majima
Journal:  Br J Pharmacol       Date:  1999-01       Impact factor: 8.739

2.  Role of tachykinins in enhancement of bradykinin-induced bronchoconstriction by captopril.

Authors:  M Arakawa; M Majima; K Nagai; F Goto; M Katori
Journal:  Inflamm Res       Date:  1996-02       Impact factor: 4.575

3.  Determination of bradykinin-(1-5) in inflammatory exudate by a new ELISA as a reliable indicator of bradykinin generation.

Authors:  M Majima; K Nishiyama; Y Iguchi; K Yao; M Ogino; T Ohno; N Sunahara; K Katoh; N Tatemichi; Y Takei; M Katori
Journal:  Inflamm Res       Date:  1996-08       Impact factor: 4.575

4.  Effect of prolonged administration of a urinary kinase inhibitor, ebelactone B on the development of deoxycorticosterone acetate-salt hypertension in rats.

Authors:  H Ito; M Majima; S Nakajima; I Hayashi; M Katori; T Izumi
Journal:  Br J Pharmacol       Date:  1999-02       Impact factor: 8.739

5.  In vivo transfer of antisense oligonucleotide against urinary kininase blunts deoxycorticosterone acetate-salt hypertension in rats.

Authors:  I Hayashi; M Majima; T Fujita; T Okumura; Y Kumagai; N Tomita; R Morishita; J Higaki; T Ogiwara
Journal:  Br J Pharmacol       Date:  2000-10       Impact factor: 8.739

Review 6.  A Novel Category of Anti-Hypertensive Drugs for Treating Salt-Sensitive Hypertension on the Basis of a New Development Concept.

Authors:  Makoto Katori; Masataka Majima
Journal:  Pharmaceuticals (Basel)       Date:  2010-01-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.